Serotonin Expression and β‐Cell Phenotype Are Associated With Indolent Behavior in Pancreatic Neuroendocrine Tumors With Sclerosing Morphology
Journal of Surgical Oncology · 2026-06 · 133 (7) · 934-941
DOI: 10.1002/jso.70247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 05.04.2026. Verfasst von Annika L Windon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Serotonin, Pancreatic Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and Objectives ARX and PDX1 transcription factors have been considered indicators of the cell of origin for pancreatic neuroendocrine tumors (PanNETs). Some PanNETs show dense fibrosis (sclerosing morphology) and an association with serotonin expression. This study aimed to explore ARX and PDX1 expression in these tumors.
Methods
Pathology archives were searched from 2005 to 2019 for PanNETs with dense stromal fibrosis. Immunohistochemical stains for ARX, PDX1, and serotonin were performed and reviewed with pertinent clinical findings.
Results
Fifty‐one PanNETs were evaluated. Serotonin expression was identified in 19 (37%) tumors. The mean tumor size was smaller in the serotonin‐expressing group compared to the non‐expressing group (1.7 ± 1.1 vs. 2.5 ± 1.2 cm, p = 0.03). Serotonin‐expressing tumors demonstrated a β‐cell phenotype with absence of ARX expression in the majority of tumors ( n = 16; 84.2%), while the non‐expressing tumors demonstrated an α‐cell phenotype with ARX expression ( n = 24, 75%, p < 0.01). Synchronous/metachronous liver metastasis was more frequent in the serotonin non‐expressing tumors ( p = 0.020). Serotonin expression was associated with a better disease‐free survival.
Conclusions
Serotonin‐expressing PanNETs more commonly showed a β‐cell phenotype, while non‐expressing tumors favored an α‐cell phenotype with more frequent liver metastasis. The expression of serotonin suggests more indolent behavior in this variant of PanNETs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
ORCID-Profile: Annika L Windon
Zitieren
APA
Windon, A. L., Revetta, F., Chen, W., & Shi, C. (2026). Serotonin Expression and β‐Cell Phenotype Are Associated With Indolent Behavior in Pancreatic Neuroendocrine Tumors With Sclerosing Morphology. Journal of Surgical Oncology, 133(7), 934-941. https://doi.org/10.1002/jso.70247
Vancouver
Windon AL, Revetta F, Chen W, Shi C. Serotonin Expression and β‐Cell Phenotype Are Associated With Indolent Behavior in Pancreatic Neuroendocrine Tumors With Sclerosing Morphology. Journal of Surgical Oncology. 2026;133(7):934-941. doi:10.1002/jso.70247
BibTeX
@article{Windon2026,
author = {Windon, Annika L and Revetta, Frank and Chen, Wei and Shi, Chanjuan},
title = {Serotonin Expression and β‐Cell Phenotype Are Associated With Indolent Behavior in Pancreatic Neuroendocrine Tumors With Sclerosing Morphology},
journal = {Journal of Surgical Oncology},
year = {2026},
volume = {133},
number = {7},
pages = {934--941},
doi = {10.1002/jso.70247}
}
EUVIMED